Blood Pressure Time in Target Range and its Impact on Clinical Outcomes

被引:0
作者
Al-Dalakta, Astefanos [1 ]
Tabaja, Chadi [1 ]
Motairek, Issam [1 ]
El Hajjar, Abdel Hadi [1 ]
Agarwal, Neel [2 ]
St. John, Julie [3 ]
Laffin, Luke J. [3 ,4 ]
机构
[1] Cleveland Clin, Dept Internal Med, 9500 Euclid Ave, Cleveland Hts, OH 44195 USA
[2] Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA
[3] Cleveland Clin, C5Research, 9500 Euclid Ave, Cleveland, OH 44195 USA
[4] Cleveland Clin Fdn, Dept Cardiovasc Med, Sect Prevent Cardiol & Rehabil, 9500 Euclid Ave,Mail Code JB1, Cleveland, OH 44195 USA
关键词
Hypertension; Time in target range; Time in therapeutic range; Cardiovascular disease; Cardiovascular disease prevention; Cardiovascular outcomes; 2017; AMERICAN-COLLEGE; ATRIAL-FIBRILLATION; CARDIOVASCULAR-DISEASE; ORAL ANTICOAGULANT; YOUNG-ADULTS; ASSOCIATION; CLASSIFICATION; HYPERTENSION; QUALITY; BENEFIT;
D O I
10.1007/s11886-024-02111-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of ReviewTo examine the concept of time in target range for blood pressure (BP) management, exploring its calculation methods, implications for patient outcomes, and potential use in patient care.Recent FindingsRecent post-hoc analyses of clinical trials and observational studies highlight the importance of BP time in target range in predicting cardiovascular outcomes. Higher time in target range correlates with reduced risks of major adverse cardiovascular events including heart failure, stroke, myocardial infarction and all-cause mortality. Additionally, longer time in target range decreases the risk of incident atrial fibrillation and risk of developing dementia.SummaryBP time in target range is a novel metric offering valuable insights into BP control and its impact on clinical outcomes. Higher time in target range is consistently associated with better cardiovascular outcomes across various patient populations. However, the clinical application of BP time in target range requires further investigation through prospective clinical trials and real-world studies. Integrating wearable devices for continuous BP monitoring could enhance the practical utility of BP time in target range in hypertension management.
引用
收藏
页码:1145 / 1151
页数:7
相关论文
共 40 条
  • [1] SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI [10.1056/NEJMx170008, 10.1056/NEJMoa1511939]
  • [2] ABC of hypertension - Blood pressure measurement Part II - Conventional sphygmomanometry: technique of auscultatory blood pressure measurement
    Beevers, G
    Lip, GYH
    O'Brien, E
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7293): : 1043 - 1047
  • [3] Accuracy of Detecting Atrial Fibrillation: A Systematic Review and Meta-Analysis of Wrist-Worn Wearable Technology
    Belani, Seema
    Wahood, Waseem
    Hardigan, Patrick
    Placzek, Andon N.
    Ely, Stephen
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [4] Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events
    Buckley, Leo F.
    Baker, William L.
    Van Tassell, Benjamin W.
    Cohen, Jordana B.
    Alkhezi, Omar
    Bress, Adam P.
    Dixon, Dave L.
    [J]. HYPERTENSION, 2023, 80 (02) : 305 - 313
  • [5] Longer time in blood pressure target range improves cardiovascular outcomes among patients with Type 2 diabetes: A secondary analysis of a randomized clinical trial
    Chen, KangYu
    Wu, Zhenqiang
    Shi, Rui
    Wang, Qi
    Yuan, Xiaodan
    Wu, Guohong
    Shi, Guoshuai
    Li, Chao
    Chen, Tao
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 198
  • [6] Prognostic Value of Time in Blood Pressure Target Range Among Patients With Heart Failure
    Chen, Kangyu
    Li, Chao
    Cornelius, Victoria
    Yu, Dahai
    Wang, Qi
    Shi, Rui
    Wu, Zhenqiang
    Su, Hao
    Yan, Ji
    Chen, Tao
    Jiang, Zhixin
    [J]. JACC-HEART FAILURE, 2022, 10 (06) : 369 - 379
  • [7] Time spent at blood pressure target and the risk of death and cardiovascular diseases
    Chung, Sheng-Chia
    Pujades-Rodriguez, Mar
    Duyx, Bram
    Denaxas, Spiros C.
    Pasea, Laura
    Hingorani, Aroon
    Timmis, Adam
    Williams, Bryan
    Hemingway, Harry
    [J]. PLOS ONE, 2018, 13 (09):
  • [8] Visit-to-Visit Blood Pressure Variability, Coronary Atheroma Progression, and Clinical Outcomes
    Clark, Donald, III
    Nicholls, Stephen J.
    St John, Julie
    Elshazly, Mohamed B.
    Ahmed, Haitham M.
    Khraishah, Haitham
    Nissen, Steven E.
    Puri, Rishi
    [J]. JAMA CARDIOLOGY, 2019, 4 (05) : 437 - 443
  • [9] Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
    Connolly, Stuart J.
    Pogue, Janice
    Eikelboom, John
    Flaker, Gregory
    Commerford, Patrick
    Franzosi, Maria Grazia
    Healey, Jeffrey S.
    Yusuf, Salim
    [J]. CIRCULATION, 2008, 118 (20) : 2029 - 2037
  • [10] Time in Therapeutic Range, as a Determinant of All-Cause Mortality in Patients With Hypertension
    Doumas, Michael
    Tsioufis, Costas
    Fletcher, Ross
    Amdur, Richard
    Faselis, Charles
    Papademetriou, Vasilios
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (11):